Combination therapy of renal cell carcinoma or breast cancer patients with dendritic cell vaccine and IL-2: results from a phase I/II trial

BACKGROUND: Ten cancer patients (Six renal cell carcinoma and four breast cancer patients) were treated in a phase I/II study with a vaccine composed of autologous dendritic cells (DCs) and IL-2 to evaluate the DC vaccine-related toxicity and antigen-specific immune alteration. METHODS: Cancer patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Baek, Soyoung, Kim, Choung-Soo, Kim, Sung-Bae, Kim, Yong-man, Kwon, Seog-Woon, Kim, YongMan, Kim, HyunSoo, Lee, Hyunah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213212/
https://www.ncbi.nlm.nih.gov/pubmed/22013914
http://dx.doi.org/10.1186/1479-5876-9-178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213212/
https://www.ncbi.nlm.nih.gov/pubmed/22013914
http://dx.doi.org/10.1186/1479-5876-9-178

Ejemplares similares